NDC 62135-790 – Ethosuximide
Ethosuximide 250 mg/1 · Capsule · Oral
Product NDC62135-790
Product details
- Brand name
- Ethosuximide
- Generic name
- Ethosuximide
- Labeler
- Chartwell RX, LLC
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA200892
- Marketed since
- September 9, 2015
- Listing expires
- December 31, 2026
- Pharmacologic class
- Anti-epileptic Agent
Active ingredients
- Ethosuximide 250 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 62135-790-12 | 120 CAPSULE in 1 BOTTLE (62135-790-12) | Oct 23, 2023 |
Other Ethosuximide products
- 42806-708 Ethosuximide 250 mg/1 · Capsule · Epic Pharma, LLC
- 42806-711 Ethosuximide 250 mg/1 · Capsule · Epic Pharma, LLC
- 64380-878 Ethosuximide 250 mg/1 · Capsule · Strides Pharma Science Limited
- 69452-152 Ethosuximide 250 mg/1 · Capsule, Liquid Filled · Bionpharma Inc.
- 63629-8005 Ethosuximide 250 mg/1 · Capsule, Liquid Filled · Bryant Ranch Prepack
- 68999-064 Ethosuximide 250 mg/5mL · Solution · Chartwell Governmental & Specialty RX, LLC.
- 62135-064 Ethosuximide 250 mg/5mL · Solution · Chartwell RX, LLC
- 59762-2350 Ethosuximide 250 mg/5mL · Solution · Mylan Pharmaceuticals Inc.
- 0121-0670 Ethosuximide 250 mg/5mL · Solution · PAI Holdings, LLC dba PAI Pharma